Arnold von Eckardstein

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

Florian Kronenberg, Samia Mora, Erik S.G. Stroes et al. · European Heart Journal · 2022 · 1.1K citations · Full text

Vascular Disease, Cardiometabolic Risk, Hyperlipidemia +22

Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

Børge G. Nordestgaard, Anne Langsted, Samia Mora et al. · European Heart Journal · 2016 · 797 citations · Full text

Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease

Christian Besler, Kathrin Heinrich, Lucia Rohrer et al. · Journal of Clinical Investigation · 2011 · 525 citations

Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men

Gerd Assmann, H. Schulte, Arnold von Eckardstein · The American Journal of Cardiology · 1996 · 454 citations

Metabolic Syndrome, Middle-aged Men, Cardiovascular Epidemiology +14

Endothelial-Vasoprotective Effects of High-Density Lipoprotein Are Impaired in Patients With Type 2 Diabetes Mellitus but Are Improved After Extended-Release Niacin Therapy

Sajoscha Sorrentino, Christian Besler, Lucia Rohrer et al. · Circulation · 2009 · 399 citations · Full text